Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Conort

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Virchows Archiv : an International Journal of Pathology|October 23, 2013
HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial originJustine Varinot, Olivier Cussenot, Morgan Roupret, et al.
European Radiology|June 29, 2004
Helical CT evaluation of the chemical composition of urinary tract calculi with a discriminant analysis of CT-attenuation values and densityMarie-France Bellin, Raphaëlle Renard-Penna, Pierre Conort, et al.
World Journal of Urology|June 27, 2008
Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancerVincent Misraï, Morgan Rouprêt, Emmanuel Chartier-Kastler, et al.
Virchows Archiv : an International Journal of Pathology|February 12, 2013
Different subtypes of carcinoma in situ of the bladder do not have a different prognosisEva Compérat, Solene-Florence Jacquet, Justine Varinot, et al.
Urology|June 13, 2006
Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinomaMorgan Rouprêt, Vincent Hupertan, Olivier Traxer, et al.
Urologia Internationalis|May 15, 2009
Aurora-A/STK-15 is differentially expressed in the micropapillary variant of bladder cancerEva Compérat, Morgan Roupret, Pierre Conort, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 9, 2005
[Percutaneous nephrolithotomy (PCNL) in subjects over the age of 70: a multicentre retrospective study of 210 cases]Bertrand Doré, Pierre Conort, Jacques Irani, et al.
The Journal of Urology|November 18, 2008
Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cmMatthieu Peycelon, Vincent Hupertan, Eva Comperat, et al.
Journal of Endourology|May 29, 2009
Promising functional outcomes obtained with robot-assisted laparoscopic pyeloplasty: a single-center experienceKarim Ferhi, Morgan Rouprêt, Julie Rode, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|January 23, 2014
Current evidence for transurethral en bloc resection of non-muscle-invasive bladder cancerMario W Kramer, Islam F Abdelkawi, Mathias Wolters, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Virchows Archiv : an International Journal of Pathology|October 23, 2013
HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial originJustine Varinot, Olivier Cussenot, Morgan Roupret, et al.
European Radiology|June 29, 2004
Helical CT evaluation of the chemical composition of urinary tract calculi with a discriminant analysis of CT-attenuation values and densityMarie-France Bellin, Raphaëlle Renard-Penna, Pierre Conort, et al.
World Journal of Urology|June 27, 2008
Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancerVincent Misraï, Morgan Rouprêt, Emmanuel Chartier-Kastler, et al.
Virchows Archiv : an International Journal of Pathology|February 12, 2013
Different subtypes of carcinoma in situ of the bladder do not have a different prognosisEva Compérat, Solene-Florence Jacquet, Justine Varinot, et al.
Urology|June 13, 2006
Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinomaMorgan Rouprêt, Vincent Hupertan, Olivier Traxer, et al.
Urologia Internationalis|May 15, 2009
Aurora-A/STK-15 is differentially expressed in the micropapillary variant of bladder cancerEva Compérat, Morgan Roupret, Pierre Conort, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 9, 2005
[Percutaneous nephrolithotomy (PCNL) in subjects over the age of 70: a multicentre retrospective study of 210 cases]Bertrand Doré, Pierre Conort, Jacques Irani, et al.
The Journal of Urology|November 18, 2008
Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cmMatthieu Peycelon, Vincent Hupertan, Eva Comperat, et al.
Journal of Endourology|May 29, 2009
Promising functional outcomes obtained with robot-assisted laparoscopic pyeloplasty: a single-center experienceKarim Ferhi, Morgan Rouprêt, Julie Rode, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|January 23, 2014
Current evidence for transurethral en bloc resection of non-muscle-invasive bladder cancerMario W Kramer, Islam F Abdelkawi, Mathias Wolters, et al.
Pageof 5